logo
episode-header-image
Sep 2023
18m 47s

Systemic Therapy for Tumor Control in Me...

AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)
About this episode

Dr. Jaydira Del Rivero and Dr. Kimberly Perez discuss the latest ASCO guideline featuring evidence-based recommendations on systemic therapy for well-differentiated grade 1 to grade 3 metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs). They discuss the recommendations, insights from the guideline expert panel, impact for clinicians and patients, and outstanding questions in the field. Read the full guideline update, "Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline” at www.asco.org/gastrointestinal-cancer-guidelines.

Up next
Jul 21
Oncology Medical Homes: ASCO-COA Standards Update
Ms. Kim Woofter and Dr. John Cox discuss the latest updates to the evidence-based standards on oncology medical homes developed by ASCO and COA. These standards serve as the basis for the ASCO Certified program. They share the new and revised standards around topics including the ... Show More
16m 11s
Jul 17
Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2025.1 Part 2
Dr. Joshua Reuss joints that podcast to discuss the latest changes to the living guideline on stage IV NSCLC with driver alterations. He discusses the new evidence for NSCLC with EGFR mutations and NRG1 fusions and how this impacts the latest recommendations from the panel. He sh ... Show More
15m 16s
Jul 17
Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2025.1 Part 1
Dr. Lyudmila Bazhenova is back on the podcast to discuss the latest update of the living guideline on therapy for stage IV NSCLC without driver alterations. She shares the studies the Expert Panel reviewed in the first- and second-line settings, including NIPPON, HARMONi-2, and D ... Show More
11m 30s
Recommended Episodes
Jan 2021
Margaret von Mehren, MD - Personalizing and Prolonging Care in GIST: Expert Guidance on Integrating New TKI Strategies
Go online to PeerView.com/MER860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. Our understanding of the pathogenesis ... Show More
58m 21s
Oct 2023
Early-Stage Prostate Cancer: Know Your Treatment Options
Learn what you need to know about early-stage prostate cancer, from risk factors to treatment options and how to tackle their side effects. In this episode, Dr. Diane Reidy-Lagunes is joined by medical oncologist Dr. Dana Rathkopf, radiation oncologist Dr. Sean McBride, and urolo ... Show More
25m 8s
Nov 2021
Newer Nonsurgical Treatment Options for Glaucoma
Drs. Lorraine Provencher and Matthew Emanuel join the show to discuss current nonsurgical management options for glaucoma patients. The panel reviews new topical therapy such as rho kinase (ROCK) inhibitors, injectable therapy, and the role of selective laser trabeculoplasty (SLT ... Show More
35m 26s
May 2024
Identifying and Treating Thrombocytopenia: Expert Advice for GPs
In this episode of The Good GP, host Dr Tim Koh welcomes distinguished guest Professor Chan Cheah, a clinical and laboratory-based haematologist with a special interest in lymphoma. Professor Cheah, who practises at Sir Charles Gairdner Hospital and works with Western Diagnostic ... Show More
22m 14s
Nov 2020
Concetta (Connie) DiDomenico, RN, MSN, PNP-BC, CPHON / Michael J. Fisher, MD - Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1, Plexiform Neurofibromas, and Optic Pathway Gliomas: Improving
Go online to PeerView.com/BQF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Neurofibromatosis type 1 (NF-1) is a rare autosomal dominant disorder of the nervous system that is associated with significant morbidity, includin ... Show More
1h 4m
Jan 2022
Journal Review in Surgical Oncology: Perioperative Chemotherapy for Locally Advanced, Resectable, Gastric Cancer
Chemotherapy or surgery first? What is the contemporary management for patients with locally advanced, resectable gastric cancer, and what does the data show? In this episode from the Surgical Oncology team at Behind the Knife, join the discussion on perioperative treatment of lo ... Show More
23m 54s
Sep 2022
2021 WHO Central Nervous System Tumor Classification
Dr. Francis Deng discusses key highlights of the 2021 WHO Central Nervous System Classification with Dr. Derek Johnson. "A Radiologist's Guide to the 2021 WHO Central Nervous System Tumor Classification: Part 1 - Key Concepts and the Spectrum of Diffuse Glioma" A Radiologist’s Gu ... Show More
18m 45s
Jul 2023
Transatlantic Series: Carotid Guidelines with Dr. A AbuRahma and Dr. B Rantner
Modern-day evidence-based medicine mandates a strong understanding of current local and international guidelines. Surgeons rely heavily on these reports, but what to do when they differ? We have partnered with the ESVS podcast in creating the Transatlantic Series, where we compar ... Show More
59m 12s
Jan 2023
VERDICT analysis for prostate MRI
Dr. Refky Nicola discusses the role of Vascular, Extracellular, and Restricted Diffusion for Cytometry in Tumor (VERDICT) MRI analysis in improving the classification of clinically significant prostate cancer with Dr. Valdair Muglia.  Avoiding Unnecessary Biopsy after Multiparame ... Show More
15m 6s
Mar 2023
Pediatric Electrolyte Emergencies
Announcements:  The interactive Clinical Pathways have launched and they are available for free!  — In this episode, Sam Ashoo, MD, and TR Eckler, MD, discuss the February 2023 Pediatric Emergency Medicine Practice article on Pediatric Electrolyte Emergencies: Recognition and Man ... Show More
53m 2s
Listen to millions of songs and podcasts on Anghami